Northwire Canada EditionSunday, October 18, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%

Healthcare

Page 106
  1. Nov 06, 2025 · 17:01 · NLH

    Nova Leap Health Corp. Posts Best Financial Performance in Company History with Record Q3 2025 Results

    Nova Leap Health Corp. Posts Best Financial Performance in Company History with Record Q3 2025 Results

    01
  2. Nov 06, 2025 · 17:00 · CPH

    Cipher Pharmaceuticals Reports Third Quarter 2025 Results

    Cipher Pharmaceuticals Reports Third Quarter 2025 Results

    02
  3. Nov 06, 2025 · 16:20 · HELP

    Cybin to host fiscal Q2 results call Nov. 13

    Cybin to host fiscal Q2 results call Nov. 13

    03
  4. Nov 06, 2025 · 16:12 · AGN

    Algernon arranges $500,000 private placement

    Algernon arranges $500,000 private placement

    04
  5. Nov 06, 2025 · 12:56 · MDNA

    Medicenna joins Fondazione Melanoma for MDNA11 trial

    Medicenna joins Fondazione Melanoma for MDNA11 trial

    05
  6. Nov 06, 2025 · 12:11 · DRUG

    Bright Minds launches Prader-Willi program

    Bright Minds launches Prader-Willi program

    06
  7. Nov 06, 2025 · 09:19 · PCRX

    PharmaCorp Announces Upsized C$20 Million Bought Deal Public Offering

    PharmaCorp Announces Upsized C$20 Million Bought Deal Public Offering

    07
  8. Nov 06, 2025 · 09:00 · MBIO

    MindBio Therapeutics Completes Dosing in Landmark Take-Home Phase 2B Microdosing Depression Trial

    MindBio Therapeutics Completes Dosing in Landmark Take-Home Phase 2B Microdosing Depression Trial

    08
  9. Nov 06, 2025 · 08:50 · VPT

    Ventripoint Announces Debt Settlement Agreements

    Ventripoint Announces Debt Settlement Agreements

    09
  10. Nov 06, 2025 · 07:30 · GUD

    Knight Therapeutics Reports Third Quarter 2025 Results

    Knight Therapeutics Reports Third Quarter 2025 Results

    10
  11. Nov 06, 2025 · 07:04 · AGN

    Algernon Health Announces Private Placement

    Algernon Health Announces Private Placement

    11
  12. Nov 06, 2025 · 07:01 · WELL

    WELL Health Reports Record Revenue, Record Adjusted EBITDA, and Record Adjusted Net Income in Q3-2025 Driven by Strong Performance in Core Canadian Businesses

    WELL Health Reports Record Revenue, Record Adjusted EBITDA, and Record Adjusted Net Income in Q3-2025 Driven by Strong Performance in Core Canadian Businesses

    12
  13. Nov 06, 2025 · 07:00 · DR

    Medical Facilities Corporation Announces Third Quarter Results

    Medical Facilities Corporation Announces Third Quarter Results

    13
  14. Nov 06, 2025 · 07:00 · MDNA

    Medicenna and Fondazione Melanoma Onlus Collaborate to Advance MDNA11 Before First-Line Therapy in a Randomized Neoadjuvant Combination Trial, "NEO-CYT", in High-Risk, Surgically Resectable Stage III Melanoma

    Medicenna and Fondazione Melanoma Onlus Collaborate to Advance MDNA11 Before First-Line Therapy in a Randomized Neoadjuvant Combination Trial, "NEO-CYT", in High-Risk, Surgically Resectable Stage III Melanoma

    14
← Newer Older →